title: Subcutaneous vs. intravenous immunoglobulin in CIDP: pharmacokinetic and clinical response.
authors.affiliation: Department of Neuroscience, University of Turin, Turin, Italy.
authors.forename: Dario
authors.initials: D
authors.lastname: Cocito
authors.affiliation: Department of Neuroscience, University of Turin, Turin, Italy.
authors.forename: Alberto
authors.initials: A
authors.lastname: Romagnolo
authors.affiliation: Department of Neuroscience, University of Turin, Turin, Italy.
authors.forename: Erdita
authors.initials: E
authors.lastname: Peci
authors.affiliation: Department of Neuroscience, University of Turin, Turin, Italy.
authors.forename: Michela
authors.initials: M
authors.lastname: Rosso
authors.affiliation: Department of Neuroscience, University of Turin, Turin, Italy.
authors.forename: Leonardo
authors.initials: L
authors.lastname: Lopiano
authors.affiliation: Department of Drug Science and Technology, University of Turin, Turin, Italy.
authors.forename: Paola
authors.initials: P
authors.lastname: Milla
authors.affiliation: Department of Neuroscience, University of Turin, Turin, Italy.
authors.forename: Aristide
authors.initials: A
authors.lastname: Merola
mesh_terms: D000279:Administration, Cutaneous; D000328:Adult; D000368:Aged; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007136:Immunoglobulins / Q000008:administration & dosage*; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D020277:Polyradiculoneuropathy, Chronic Inflammatory Demyelinating / Q000188:drug therapy*; D016896:Treatment Outcome
chemical_list: D007136:Immunoglobulins; D016756:Immunoglobulins, Intravenous